TP-122, Excipient mixture (solvent):Sodium Chloride 0.9% w/v clinical trials

A Randomized, Parallel, Open-Label, Phase 1/2a Study to Assess the Safety and Tolerability of Multiple Doses of the Bacteriophage Cocktail TP-122 (Component TP-122A), for the Treatment of Ventilator-Associated Pneumonia

This study is testing a new treatment called TP-122 for a serious lung infection called ventilator-associated pneumonia. Researchers want to see if it's safe, how well people tolerate it, and if it helps patients get better faster when added to standard care.